The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies

The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies

It is often argued that DNA nanotechnology has a multitude of possible applications. However, despite great advances in the understanding of the fundamental principles of the field, to date, there has been comparatively little commercial activity. Analysis of patent applications and company case stu...

Full description

Bibliographic Details
Main Author: Katherine E. Dunn
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Molecules
Subjects:
dna nanotechnology
dna origami
patents
commercialization
Online Access:https://www.mdpi.com/1420-3049/25/2/377
id doaj-223a5081ba2c4069a77b31ff4586af2d
record_format Article
spelling doaj-223a5081ba2c4069a77b31ff4586af2d2020-11-25T01:10:11ZengMDPI AGMolecules1420-30492020-01-0125237710.3390/molecules25020377molecules25020377The Business of DNA Nanotechnology: Commercialization of Origami and Other TechnologiesKatherine E. Dunn0School of Engineering, Institute for Bioengineering, University of Edinburgh, The King’s Buildings, Edinburgh, Scotland EH9 3DW, UKIt is often argued that DNA nanotechnology has a multitude of possible applications. However, despite great advances in the understanding of the fundamental principles of the field, to date, there has been comparatively little commercial activity. Analysis of patent applications and company case studies suggests that this is now starting to change. The number of patent application filings is increasing, and new companies are being formed to exploit technologies based on nanoscale structures and devices made from DNA. There are parallels between the commercial developments in this field and those observed in other areas of innovation. Further commercialization is expected and new players will emerge.https://www.mdpi.com/1420-3049/25/2/377dna nanotechnologydna origamipatentscommercialization
collection DOAJ
language English
format Article
sources DOAJ
author Katherine E. Dunn
spellingShingle Katherine E. Dunn
The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies
Molecules
dna nanotechnology
dna origami
patents
commercialization
author_facet Katherine E. Dunn
author_sort Katherine E. Dunn
title The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies
title_short The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies
title_full The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies
title_fullStr The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies
title_full_unstemmed The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies
title_sort business of dna nanotechnology: commercialization of origami and other technologies
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2020-01-01
description It is often argued that DNA nanotechnology has a multitude of possible applications. However, despite great advances in the understanding of the fundamental principles of the field, to date, there has been comparatively little commercial activity. Analysis of patent applications and company case studies suggests that this is now starting to change. The number of patent application filings is increasing, and new companies are being formed to exploit technologies based on nanoscale structures and devices made from DNA. There are parallels between the commercial developments in this field and those observed in other areas of innovation. Further commercialization is expected and new players will emerge.
topic dna nanotechnology
dna origami
patents
commercialization
url https://www.mdpi.com/1420-3049/25/2/377
work_keys_str_mv AT katherineedunn thebusinessofdnananotechnologycommercializationoforigamiandothertechnologies
AT katherineedunn businessofdnananotechnologycommercializationoforigamiandothertechnologies
_version_ 1725176373036711936

Similar Items